Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1988 2
1990 1
1991 1
1992 1
1996 2
1997 2
2000 2
2001 2
2002 1
2003 1
2005 2
2006 2
2007 8
2008 7
2009 2
2010 3
2011 13
2012 16
2013 14
2014 17
2015 36
2016 43
2017 50
2018 33
2019 57
2020 45
2021 44
2022 70
2023 65
2024 65
2025 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

579 results

Results by year

Filters applied: . Clear all
Page 1
Hypothyroidism.
Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Chaker L, et al. Nat Rev Dis Primers. 2022 May 19;8(1):30. doi: 10.1038/s41572-022-00357-7. Nat Rev Dis Primers. 2022. PMID: 35589725 Review.
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches.
Sheibani M, Azizi Y, Shayan M, Nezamoleslami S, Eslami F, Farjoo MH, Dehpour AR. Sheibani M, et al. Cardiovasc Toxicol. 2022 Apr;22(4):292-310. doi: 10.1007/s12012-022-09721-1. Epub 2022 Jan 21. Cardiovasc Toxicol. 2022. PMID: 35061218 Review.
Doxorubicin is an effective chemotherapeutic agent prescribed to treat solid tumors (e.g., ovary, breast, and gastrointestinal cancers). This anti-cancer drug has various side effects, such as allergic reactions, cardiac damage, hair loss, bone marrow suppression, vomiting …
Doxorubicin is an effective chemotherapeutic agent prescribed to treat solid tumors (e.g., ovary, breast, and gastrointestinal cancer …
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.
Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, Salvador H, Azizi AA, Mautner V, Röhl C, Peltonen S, Stivaros S, Legius E, Oostenbrink R; ERN GENTURIS NF1 Tumour Management Guideline Group. Carton C, et al. EClinicalMedicine. 2023 Jan 13;56:101818. doi: 10.1016/j.eclinm.2022.101818. eCollection 2023 Feb. EClinicalMedicine. 2023. PMID: 36684394 Free PMC article. Review.
SIOP-E-BTG and GPOH Guidelines for Diagnosis and Treatment of Children and Adolescents with Low Grade Glioma.
Gnekow AK, Kandels D, Tilburg CV, Azizi AA, Opocher E, Stokland T, Driever PH, Schouten-van Meeteren AYN, Thomale UW, Schuhmann MU, Czech T, Goodden JR, Warmuth-Metz M, Bison B, Avula S, Kortmann RD, Timmermann B, Pietsch T, Witt O. Gnekow AK, et al. Klin Padiatr. 2019 May;231(3):107-135. doi: 10.1055/a-0889-8256. Epub 2019 May 20. Klin Padiatr. 2019. PMID: 31108561 English.
Overall survival is around 90%, and many patients survive with residual tumor, i. e. they suffer from chronic disease. All patients need comprehensive neuro-oncological care, the principles and details of which are summarized in the current guidelines. ...The current treat …
Overall survival is around 90%, and many patients survive with residual tumor, i. e. they suffer from chronic disease. All patients n …
The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review.
Bian D, Wu Y, Song G, Azizi R, Zamani A. Bian D, et al. Stem Cell Res Ther. 2022 Jan 24;13(1):24. doi: 10.1186/s13287-021-02697-9. Stem Cell Res Ther. 2022. PMID: 35073970 Free PMC article. Review.
Since the chief healing properties of the MSCs depend on their paracrine effects, it appears that MSCs-derived exosomes also can be an alternative option to support wound healing and skin regeneration as an innovative cell-free approach. Such exosomes convey functional cargos ( …
Since the chief healing properties of the MSCs depend on their paracrine effects, it appears that MSCs-derived exosomes also can be an alter …
The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases.
Berry SPD, Dossou C, Kashif A, Sharifinejad N, Azizi G, Hamedifar H, Sabzvari A, Zian Z. Berry SPD, et al. Int Immunopharmacol. 2022 Jan;102:108402. doi: 10.1016/j.intimp.2021.108402. Epub 2021 Dec 1. Int Immunopharmacol. 2022. PMID: 34863654 Review.
Critical evaluation of the mAbs targeting IL-17A and IL-17 receptors (e.g., Ixekizumab, Secukinumab, and Brodalumab) in various immune-mediated diseases will be provided, and finally, their clinical efficacy and safety will be reported....
Critical evaluation of the mAbs targeting IL-17A and IL-17 receptors (e.g., Ixekizumab, Secukinumab, and Brodalumab) in various immun …
Antithyroid Drugs.
Abdi H, Amouzegar A, Azizi F. Abdi H, et al. Iran J Pharm Res. 2019 Fall;18(Suppl1):1-12. doi: 10.22037/ijpr.2020.112892.14005. Iran J Pharm Res. 2019. PMID: 32802086 Free PMC article. Review.
The thionamide drugs, i.e. carbimazole and its metabolite methimazole (MMI), and propylthiouracil (PTU) have extensively been used in the management of various forms of hyperthyroidism over the past eight decades. ...
The thionamide drugs, i.e. carbimazole and its metabolite methimazole (MMI), and propylthiouracil (PTU) have extensively been used in …
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach.
Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M, Azizi G. Aliyu M, et al. Int Immunopharmacol. 2022 Oct;111:109130. doi: 10.1016/j.intimp.2022.109130. Epub 2022 Aug 12. Int Immunopharmacol. 2022. PMID: 35969896 Review.
There are two classes of approved IL-6 inhibitors: anti-IL-6 receptor monoclonal antibodies (e.g., tocilizumab) and anti-IL-6 monoclonal antibodies (i.e., siltuximab). These drugs have been evaluated in patients with rheumatoid arthritis, juvenile idiopathic arthrit …
There are two classes of approved IL-6 inhibitors: anti-IL-6 receptor monoclonal antibodies (e.g., tocilizumab) and anti-IL-6 monoclo …
579 results